Skip to main content

TWO SIGMA INVESTMENTS, LP

Position in ASND — Ascendis Pharma A/S

CIK 1179392 NEW YORK, NY

Position in ASND

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$50,398,596
-$2,461,894 QoQ
Shares Held
220,341
-11.1% QoQ
Ownership
0.336%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority Sole 99.77307900027684.ToString("F0")% Shared 0.ToString("F0")% None 0.22692099972315638.ToString("F0")%

Common Shares in ASND Over Time

Shares Held

Position Value (USD)

Derivatives in ASND

reported options exposure · as of Mar 31, 2026
CallValue
$320,222
CallShares
1,400
PutValue
$846,301
PutShares
3,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

TWO SIGMA INVESTMENTS, LP holds $5,502,861,072 across 315 Biotechnology names. ASND ranks #22 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ASND

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $320,222 1,400
2026-03-31 $50,398,596 220,341
2026-03-31 $846,301 3,700
2025-12-31 $52,860,490 247,892
2025-09-30 $36,558,375 183,886
2025-06-30 $537,649 3,115
2025-03-31 $2,924,089 18,761
2024-12-31 $1,502,668 10,915
2024-09-30 $7,478,639 50,088
2024-06-30 $34,820,541 255,320
2024-03-31 $31,794,830 210,325